{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:33:42Z","timestamp":1790948022045,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jpba.2016.11.040","type":"journal-article","created":{"date-parts":[[2016,11,27]],"date-time":"2016-11-27T02:30:19Z","timestamp":1480213819000},"page":"158-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Metabolic fate and detectability of the new psychoactive substances 2-(4-bromo-2,5-dimethoxyphenyl)- N- [(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe) and 2-(4-chloro-2,5-dimethoxyphenyl)- N- [(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) in human and rat urine by GC\u2013MS, LC\u2013MS n , and LC\u2013HR\u2013MS\/MS approaches"],"prefix":"10.1016","volume":"134","author":[{"given":"Achim T.","family":"Caspar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon D.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas E.","family":"Stoever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus R.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans H.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2016.11.040_bib0005","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), New psychoactive substances in Europe. An update from the EU Early Warning System (2015)."},{"key":"10.1016\/j.jpba.2016.11.040_bib0010","series-title":"World Drug Report 2014","author":"United Nations Office on Drugs and Crime (UNODC)","year":"2014"},{"key":"10.1016\/j.jpba.2016.11.040_bib0015","series-title":"World Drug Report 2015","author":"United Nations Office on Drugs and Crime (UNODC)","year":"2015"},{"key":"10.1016\/j.jpba.2016.11.040_bib0020","series-title":"World Drug Report 2016","author":"United Nations Office on Drugs and Crime (UNODC)","year":"2016"},{"key":"10.1016\/j.jpba.2016.11.040_bib0025","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/FTD.0b013e3181eea318","article-title":"Chemistry pharmacology, and metabolism of emerging drugs of abuse [review]","volume":"32","author":"Maurer","year":"2010","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2016.11.040_bib0030","article-title":"New phenethylamines in Europe","author":"King","year":"2013","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2016.11.040_bib0035","series-title":"Pihkal, A Chemical Love Story","author":"Shulgin","year":"1991"},{"key":"10.1016\/j.jpba.2016.11.040_bib0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.psym.2014.11.002","article-title":"Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature","volume":"56","author":"Suzuki","year":"2015","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jpba.2016.11.040_bib0045","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1124\/mol.106.028720","article-title":"Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists","volume":"70","author":"Braden","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jpba.2016.11.040_bib0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1021\/cn400216u","article-title":"Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A\/2C agonists","volume":"5","author":"Hansen","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jpba.2016.11.040_bib0055","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2013.08.025","article-title":"Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response","volume":"77","author":"Halberstadt","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpba.2016.11.040_bib0060","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1021\/cn500292d","article-title":"N-Benzyl-5-methoxytryptamines as potent serotonin 5-HT2 receptor family agonists and comparison with a series of phenethylamine analogues","volume":"6","author":"Nichols","year":"2015","journal-title":"ACS. Chem. Neurosci."},{"key":"10.1016\/j.jpba.2016.11.040_bib0065","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/0269881114523866","article-title":"The NBOMe hallucinogenic drug series: patterns of use, characteristics of users and self-reported effects in a large international sample","volume":"28","author":"Lawn","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpba.2016.11.040_bib0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.forsciint.2012.08.027","article-title":"25C-NBOMe \u2212 New potent hallucinogenic substance identified on the drug market","volume":"227","author":"Zuba","year":"2013","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2016.11.040_bib0075","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/15563650.2013.802795","article-title":"Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series","volume":"51","author":"Hill","year":"2013","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.jpba.2016.11.040_bib0080","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.forsciint.2013.10.015","article-title":"Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death","volume":"234","author":"Poklis","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2016.11.040_bib0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13181-013-0314-y","article-title":"2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing","volume":"10","author":"Stellpflug","year":"2014","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.jpba.2016.11.040_bib0090","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/15563650.2014.909932","article-title":"Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe","volume":"52","author":"Tang","year":"2014","journal-title":"Clin. Toxicol. (Phila)"},{"key":"10.1016\/j.jpba.2016.11.040_bib0095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/02791072.2014.960111","article-title":"My friend said it was good LSD: a suicide attempt following analytically confirmed 25I-NBOMe ingestion","volume":"46","author":"Suzuki","year":"2014","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.jpba.2016.11.040_bib0100","doi-asserted-by":"crossref","first-page":"734749","DOI":"10.1155\/2014\/734749","article-title":"P.F. Bolzan Mariotti, E., Cinosi, P., Simonato, G., Martinotti, G., Bersani, F. Schifano, 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug","volume":"2014","author":"Bersani","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jpba.2016.11.040_bib0105","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/dta.1522","article-title":"Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication","volume":"6","author":"Poklis","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2016.11.040_bib0110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/PAF.0000000000000082","article-title":"Pathological findings in 2 cases of fatal 25I-NBOMe toxicity","volume":"35","author":"Walterscheid","year":"2014","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"10.1016\/j.jpba.2016.11.040_bib0115","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/jcbfm.2014.68","article-title":"Serotonin 2A receptor agonist binding in the human brain with [(1)(1)C]Cimbi-36","volume":"34","author":"Ettrup","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jpba.2016.11.040_bib0120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuroimage.2016.02.001","article-title":"Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin","volume":"130","author":"Ettrup","year":"2016","journal-title":"Neuroimage"},{"key":"10.1016\/j.jpba.2016.11.040_bib0125","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1007\/s00216-015-8828-6","article-title":"Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC\u2013MS, LC\u2013MSn, and LC\u2013HR\u2013MS\/MS","volume":"407","author":"Caspar","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2016.11.040_bib0130","article-title":"25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry","author":"Wohlfarth","year":"2016","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2016.11.040_bib0135","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/dta.1865","article-title":"In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS","volume":"8","author":"Boumrah","year":"2016","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2016.11.040_bib0140","article-title":"Metabolic fate of hallucinogenic NBOMes","author":"Leth-Petersen","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jpba.2016.11.040_bib0145","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00216-014-8360-0","article-title":"Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC\u2013MS and LC\u2013(HR)\u2013MSn techniques","volume":"407","author":"Welter","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2016.11.040_bib0150","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1476-5381.2009.00267.x","article-title":"To scale or not to scale: the principles of dose extrapolation","volume":"157","author":"Sharma","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpba.2016.11.040_bib0155","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1007\/s00216-013-6741-4","article-title":"2-Methiopropamine, a thiophene analogue of methamphetamine: studies on its metabolism and detectability in the rat and human using GC\u2013MS and LC\u2013(HR)\u2013MS techniques","volume":"405","author":"Welter","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2016.11.040_bib0160","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1007\/s00216-016-9740-4","article-title":"Metabolic fate of desomorphine elucidated using rat urine pooled human liver preparations, and human hepatocyte cultures as well as its detectability using standard urine screening approaches","volume":"408","author":"Richter","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2016.11.040_bib0165","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00216-013-7539-0","article-title":"Dimethocaine, a synthetic cocaine derivative: studies on its in vivo metabolism and its detectability in urine by LC\u2013HR\u2013MSn and GC\u2013MS using a rat model","volume":"406","author":"Meyer","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2016.11.040_bib0170","series-title":"Mass Spectral Data of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites","author":"Maurer","year":"2016"},{"key":"10.1016\/j.jpba.2016.11.040_bib0175","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1007\/s00216-011-5032-1","article-title":"Drugs of abuse screening in urine as part of a metabolite-based LC\u2013MS(n) screening concept","volume":"400","author":"Wissenbach","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2016.11.040_bib0180","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.aca.2015.08.018","article-title":"Orbitrap technology for comprehensive metabolite-based liquid chromatographic-high resolution-tandem mass spectrometric urine drug screening \u2212 exemplified for cardiovascular drugs","volume":"891","author":"Helfer","year":"2015","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2016.11.040_bib0185","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jchromb.2006.08.049","article-title":"Studies on the toxicological detection of the designer drug 4-bromo-2,5-dimethoxy-beta-phenethylamine (2C-B) in rat urine using gas chromatography-mass spectrometry","volume":"846","author":"Theobald","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2016.11.040_bib0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.toxlet.2015.08.012","article-title":"Toxicokinetics of lefetamine and derived diphenylethylamine designer drugs \u2212 Contribution of human cytochrome P450 isozymes to their main phase I metabolic steps","volume":"238","author":"Wink","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jpba.2016.11.040_bib0195","article-title":"Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH","author":"Nielsen","year":"2016","journal-title":"Drug Test. Anal."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170851631007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170851631007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T06:22:39Z","timestamp":1536214959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170851631007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":39,"alternative-id":["S073170851631007X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2016.11.040","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic fate and detectability of the new psychoactive substances 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe) and 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) in human and rat urine by GC\u2013MS, LC\u2013MSn, and LC\u2013HR\u2013MS\/MS approaches","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2016.11.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}